ArticleBMJ open2020

Assessing the safety and pharmacokinetics of the anti-HIV monoclonal antibody CAP256V2LS alone and in combination with VRC07-523LS and PGT121 in South African women: study protocol for the first-in-human CAPRISA 012B phase I clinical trial.

Sharana Mahomed et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.